BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 22329784)

  • 1. Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy.
    Szeimies RM; Torezan L; Niwa A; Valente N; Unger P; Kohl E; Schreml S; Babilas P; Karrer S; Festa-Neto C
    Br J Dermatol; 2012 Jul; 167(1):150-9. PubMed ID: 22329784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial.
    Miola AC; Ferreira ER; Lima TRR; Schmitt JV; Abbade LPF; Miot HA
    Br J Dermatol; 2018 Nov; 179(5):1081-1087. PubMed ID: 29862491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot split-face study comparing conventional methyl aminolevulinate-photodynamic therapy (PDT) with microneedling-assisted PDT on actinically damaged skin.
    Torezan L; Chaves Y; Niwa A; Sanches JA; Festa-Neto C; Szeimies RM
    Dermatol Surg; 2013 Aug; 39(8):1197-201. PubMed ID: 23638986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial.
    Togsverd-Bo K; Haak CS; Thaysen-Petersen D; Wulf HC; Anderson RR; Hædersdal M
    Br J Dermatol; 2012 Jun; 166(6):1262-9. PubMed ID: 22348388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
    Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short incubation fractional CO
    Vrani F; Sotiriou E; Lazaridou E; Vakirlis E; Sideris N; Kirmanidou E; Apalla Z; Lallas A; Ioannides D
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):79-83. PubMed ID: 29869444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy using intense pulsed light for treating actinic keratoses and photoaged skin of the dorsal hands: a randomized placebo-controlled study.
    Kohl E; Popp C; Zeman F; Unger P; Koller M; Landthaler M; Karrer S; Szeimies RM
    Br J Dermatol; 2017 Feb; 176(2):352-362. PubMed ID: 27518833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
    Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
    Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical efficacy of topical methyl-aminolevulinate photodynamic therapy in moderate to severe actinic keratoses of the face and scalp.
    Kleinpenning MM; van de Kerkhof PC; Gerritsen RM
    J Dermatolog Treat; 2010 Jul; 21(4):252-7. PubMed ID: 19832288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis.
    Torezan L; Grinblat B; Haedersdal M; Valente N; Festa-Neto C; Szeimies RM
    Br J Dermatol; 2018 Oct; 179(4):829-835. PubMed ID: 29476546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can photodynamic therapy reverse the signs of photoageing and field cancerization?
    Morton CA
    Br J Dermatol; 2012 Jul; 167(1):2. PubMed ID: 22738409
    [No Abstract]   [Full Text] [Related]  

  • 12. Laser-assisted MAL-PDT associated with acoustic pressure wave ultrasound with short incubation time for field cancerization treatment: A left-right comparison.
    Pires MTF; Pereira AD; Durães SMB; Issa MCA; Pires M
    Photodiagnosis Photodyn Ther; 2019 Dec; 28():216-220. PubMed ID: 31479804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of matrix metalloproteinases in photodamaged skin by photodynamic therapy.
    Almeida Issa MC; Piñeiro-Maceira J; Farias RE; Pureza M; Raggio Luiz R; Manela-Azulay M
    Br J Dermatol; 2009 Sep; 161(3):647-53. PubMed ID: 19519826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical and histologic findings in daylight photodynamic therapy for skin field cancerization: A randomized controlled four-arm study on physical methods-assisted delivery of methyl aminolevulinate.
    Bento CO; Pantaleão L; de Souza MB; Vilar EAG; Luiz RR; Filho PJS; Gismondi RAOC; Issa MCA
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102404. PubMed ID: 34133958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
    Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
    Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial.
    Wiegell SR; Haedersdal M; Eriksen P; Wulf HC
    Br J Dermatol; 2009 Jun; 160(6):1308-14. PubMed ID: 19416257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an international expert group.
    Philipp-Dormston WG; Sanclemente G; Torezan L; Tretti Clementoni M; Le Pillouer-Prost A; Cartier H; Szeimies RM; Bjerring P
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):8-15. PubMed ID: 26552049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
    Neittaanmäki-Perttu N; Karppinen TT; Grönroos M; Tani TT; Snellman E
    Br J Dermatol; 2014 Nov; 171(5):1172-80. PubMed ID: 25109244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study.
    Gracia-Cazaña T; Malinis AJG; Almagro-Sánchez M; Linares DP; Gilaberte Y
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():34-38. PubMed ID: 31141728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial.
    Togsverd-Bo K; Halldin C; Sandberg C; Gonzalez H; Wennberg AM; Sørensen SS; Wulf HC; Haedersdal M
    Br J Dermatol; 2018 Apr; 178(4):903-909. PubMed ID: 28796885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.